AMTB Amerant shares dip 492 after Q1 2026 EPS narrowly misses analyst consensus estimates AXGN Axogen Q4 2025 EPS falls nearly 30 percent short of estimates shares post modest gain today Lam Research Corporation LRCX MATCH Act Policy Scrutiny Highlights China Exposure Risks Amid Contrasting Valuation and NearTerm Momentum